Physician Wealth Advisors’s Pyxis Oncology PYXS Stock Holding History

Physician Wealth Advisors’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.84K	Hold	943	–	–	﹤0.01%	1356
2026 Q1	$1.38K	Hold	943	–	–	﹤0.01%	1511
2025 Q4	$1.08K	Hold	943	–	–	﹤0.01%	1575
2025 Q3	$2.09K	Hold	943	–	–	﹤0.01%	1204
2025 Q2	$1.04K	Buy	+943	New	+$1.06K	﹤0.01%	1403

Other funds holding PYXS

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

HIMS

Hager Investment Management Services New London, New Hampshire $217M AUM 56.89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FUBT

First United Bank & Trust Oakland, Maryland $348M AUM 25.01% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Physician Wealth Advisors's PYXS Position: Q2 2026 in Review

Physician Wealth Advisors held its Pyxis Oncology (PYXS) position steady in Q2 2026 at 943 shares worth $2.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

Physician Wealth Advisors first reported a position in PYXS in Q2 2025 and has held it in 5 quarters since. 7 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

Physician Wealth Advisors held 943 shares of Pyxis Oncology worth $2.84K as of Q2 2026.
Physician Wealth Advisors left its Pyxis Oncology share count unchanged in Q2 2026.
Pyxis Oncology made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1356 holding.
Physician Wealth Advisors first reported a position in Pyxis Oncology in Q2 2025 and has held it in 5 quarters since.
7 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.